Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
J Neurol Sci
Week 48: Final Results and Next Steps Week 48 represents the clinical trial endpoint
J Biol Chem 269:1852118528 Calsolaro V, Edison P (2015) Novel GLP-1 (glucagon-like peptide-1) analogues and insulin in the treatment for Alzheimers disease and other neurodegenerative diseases
Results vary, and not every patient is a candidate for treatment
Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial
Assessment report for GLP-1 based therapies (Article 53 procedure) EMA
US$ 20.29
US$ 22.37
US$ 21.32
US$ 24.30
US$ 20.66
